PharmGen Science Inc (004720) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.008x

Based on the latest financial reports, PharmGen Science Inc (004720) has a cash flow conversion efficiency ratio of 0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.91 Billion ≈ $1.29 Million USD) by net assets (₩247.76 Billion ≈ $167.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See PharmGen Science Inc net asset quality index to measure how much of total assets are equity-financed.

PharmGen Science Inc - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how PharmGen Science Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 004720 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

PharmGen Science Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PharmGen Science Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Humpuss Intermoda Transportasi JK:HITS	0.053x
MINDs Lab Inc. KQ:377480	-0.082x
Direct Line Insurance Group plc LSE:DLG	-0.069x
Anson Resources Limited F:9MY	-0.046x
Corline Biomedical AB ST:CLBIO	-0.072x
Daelim B&Co KO:005750	-0.002x
FatPipe, Inc. Common Stock NASDAQ:FATN	0.011x
Trisula Textile Industries Tbk PT JK:BELL	0.074x

Annual Cash Flow Conversion Efficiency for PharmGen Science Inc (2011–2024)

The table below shows the annual cash flow conversion efficiency of PharmGen Science Inc from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see how much is PharmGen Science Inc worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩249.43 Billion ≈ $169.03 Million	₩2.38 Billion ≈ $1.62 Million	0.010x	-59.89%
2023-12-31	₩228.21 Billion ≈ $154.66 Million	₩5.44 Billion ≈ $3.69 Million	0.024x	+483.79%
2022-12-31	₩207.12 Billion ≈ $140.36 Million	₩-1.29 Billion ≈ $-871.62K	-0.006x	-110.13%
2021-12-31	₩126.93 Billion ≈ $86.02 Million	₩7.78 Billion ≈ $5.28 Million	0.061x	+91.54%
2020-12-31	₩83.57 Billion ≈ $56.63 Million	₩2.68 Billion ≈ $1.81 Million	0.032x	-28.64%
2019-12-31	₩56.25 Billion ≈ $38.12 Million	₩2.52 Billion ≈ $1.71 Million	0.045x	-39.50%
2018-12-31	₩56.85 Billion ≈ $38.52 Million	₩4.22 Billion ≈ $2.86 Million	0.074x	+106.01%
2017-12-31	₩51.05 Billion ≈ $34.60 Million	₩1.84 Billion ≈ $1.25 Million	0.036x	-83.10%
2016-12-31	₩36.41 Billion ≈ $24.67 Million	₩7.75 Billion ≈ $5.26 Million	0.213x	+68.55%
2015-12-31	₩28.66 Billion ≈ $19.42 Million	₩3.62 Billion ≈ $2.45 Million	0.126x	+226.04%
2014-12-31	₩20.12 Billion ≈ $13.63 Million	₩-2.02 Billion ≈ $-1.37 Million	-0.100x	+43.17%
2013-12-31	₩23.83 Billion ≈ $16.15 Million	₩-4.20 Billion ≈ $-2.85 Million	-0.176x	-213.97%
2011-12-31	₩18.69 Billion ≈ $12.67 Million	₩2.89 Billion ≈ $1.96 Million	0.155x	--

About PharmGen Science Inc

KO:004720 Korea Drug Manufacturers - General

Market Cap

$48.26 Million

₩71.22 Billion KRW

Market Cap Rank

#21955 Global

#1308 in Korea

Share Price

₩3250.00

Change (1 day)

+3.17%

52-Week Range

₩2710.00 - ₩4615.00

All Time High

₩27300.00